Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Avacta Life Sciences Ltd
Hoffmann-La Roche
Bayer
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Health Network, Toronto
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center